How Do You Spell ANTISENSE OLIGORIBONUCLEOTIDE?

Pronunciation: [ˌantɪsˈɛns ˈɒlɪɡˌɔːɹɪbˌɒnjuːklˌɪətˌa͡ɪd] (IPA)

The spelling of the word "Antisense Oligoribonucleotide" might seem intimidating, but it's not as complicated as it looks. The word consists of four syllables: an-ti-sense o-li-go-ri-bo-nu-cle-o-tide. The phonetic transcription in IPA is /ˌæn.tiˈsɛns ˌɑl.ɪ.ɡoʊˌraɪ.boʊˈnju.kli.ə.taɪd/. This term refers to a strand of RNA that can bind to complementary mRNA and prevent gene expression. Although the spelling may look complex, breaking down the word into its syllables and understanding the IPA transcription can make it easier to read and comprehend.

ANTISENSE OLIGORIBONUCLEOTIDE Meaning and Definition

1. Antisense Oligoribonucleotide (ASO) refers to a type of short, single-stranded RNA molecule that binds to a specific messenger RNA (mRNA) sequence in order to modulate gene expression. ASOs are synthesized in a laboratory and designed to be complementary to the target mRNA, effectively blocking the process of translation, where mRNA is read and converted into proteins.

   The concept of antisense technology is based on the fact that DNA and RNA both consist of sequences of nucleotides, which can form complementary base pairs. By specifically targeting the mRNA of a particular gene, ASOs can prevent the translation of the gene into a functional protein. They achieve this by binding to the mRNA strand, making it inaccessible to the cellular machinery responsible for protein synthesis.

   ASOs have gained significant attention in the field of molecular biology and drug development due to their potential therapeutic applications. They have been investigated as a promising tool for treating various genetic diseases, including certain types of cancer, genetic disorders, and viral infections. By interfering with the expression of disease-causing genes, ASOs may help in regulating protein production and restoring normal cellular function.

   The development of ASOs involves careful design and optimization to ensure high specificity and efficiency. Chemical modifications are often incorporated into the ASO structure to improve stability, enhance target binding, and minimize degradation by cellular enzymes. The delivery of ASOs into cells can be achieved through various methods, such as direct injection, encapsulation in nanoparticles, or conjugation to specific targeting molecules.

   In summary, antisense oligoribonucleotides are short RNA molecules that bind to target mRNA sequences, interfering with protein translation and potentially offering therapeutic benefits in the treatment of genetic diseases.

Common Misspellings for ANTISENSE OLIGORIBONUCLEOTIDE

• zntisense oligoribonucleotide
• sntisense oligoribonucleotide
• wntisense oligoribonucleotide
• qntisense oligoribonucleotide
• abtisense oligoribonucleotide
• amtisense oligoribonucleotide
• ajtisense oligoribonucleotide
• ahtisense oligoribonucleotide
• anrisense oligoribonucleotide
• anfisense oligoribonucleotide
• angisense oligoribonucleotide
• anyisense oligoribonucleotide
• an6isense oligoribonucleotide
• an5isense oligoribonucleotide
• antusense oligoribonucleotide
• antjsense oligoribonucleotide
• antksense oligoribonucleotide
• antosense oligoribonucleotide
• ant9sense oligoribonucleotide
• ant8sense oligoribonucleotide

Etymology of ANTISENSE OLIGORIBONUCLEOTIDE

The word "Antisense Oligoribonucleotide" can be broken down into its constituent parts to understand its etymology:

1. Antisense: The term "antisense" derives from the Latin words "anti" (against) and "sensus" (sense). In molecular biology, "antisense" refers to a nucleotide sequence that is complementary to a specific messenger RNA (mRNA) sequence. Antisense sequences can bind to complementary RNA sequences and affect gene expression.

2. Oligoribonucleotide: "Oligo-" refers to a small or short molecule, while "ribo-" is derived from "ribonucleic acid", a type of nucleic acid. "Nucleotide" refers to the building blocks of nucleic acids.